- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02464150
Gluten Challenge in Celiac Disease
July 12, 2020 updated by: Knut E. A. Lundin, Oslo University Hospital
Up till 30 participants with celiac disease on a glutenfree diet are asked to consume gluten containing cookies or bread for 3 days.
Questionnaires and sampling of blood is done before, during and after.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Before and 6 days after start of gluten challenge, blood samples will be collected and analysed by using HLA-tetramers to identify and purify CD4+ gluten-specific T cells by flow cytometry.
T cells will undergo transcriptome analysis to get an insight in signalling of antigen-specific cells.
Other cell populations like CD8+ T cells and γδ T cells will also be analyzed by flow cytometry.
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephanie Zühlke, MD
- Phone Number: +47 23074224
- Email: stephanie.zuhlke@medisin.uio.no
Study Locations
-
-
-
Oslo, Norway, 0372
- Recruiting
- Oslo University Hospital - Rikshospitalet
-
Contact:
- Stephanie Zühlke, M.D.
- Email: stephanie.zuhlke@medisin.uio.no
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Celiac disease confirmed by biopsy
- Age 18 - 80 years
- Gluten free diet last 6 months
- Subject has received information and signed the informed consent form
Exclusion Criteria:
- Pregnant or breast feeding
- Probability of participant becoming pregnant (f.ex. by not using adequate sexual prevention by woman in fertile age)
- Drugs influencing immune system used last 3 months
- Current infectious disease of moderate or high severity
- Other chronic active intestinal disease
- Serious reaction on small amounts of gluten ingested
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Participants
Participants are subjected to gluten intervention in an unblinded fashion.
|
Challenge done in the form of a gluten containing cookie once daily, or up to four slices of regular bread daily.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Transcriptome of gluten-specific T cells
Time Frame: Day 6
|
Transcriptional differences of glutenspecific vs. unspecific T cells
|
Day 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Knut EA Lundin, MD PhD, Oslo University Hospital and University of Oslo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zuhlke S, Risnes LF, Dahal-Koirala S, Christophersen A, Sollid LM, Lundin KE. CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease. United European Gastroenterol J. 2019 Dec;7(10):1337-1344. doi: 10.1177/2050640619874183. Epub 2019 Sep 7.
- Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, Veierod MB, Henriksen C, Lundin KEA. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology. 2018 Feb;154(3):529-539.e2. doi: 10.1053/j.gastro.2017.10.040. Epub 2017 Nov 2.
- Sarna VK, Skodje GI, Reims HM, Risnes LF, Dahal-Koirala S, Sollid LM, Lundin KEA. HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge. Gut. 2018 Sep;67(9):1606-1613. doi: 10.1136/gutjnl-2017-314461. Epub 2017 Aug 4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2017
Primary Completion (ANTICIPATED)
August 1, 2028
Study Completion (ANTICIPATED)
August 1, 2028
Study Registration Dates
First Submitted
March 30, 2015
First Submitted That Met QC Criteria
June 4, 2015
First Posted (ESTIMATE)
June 8, 2015
Study Record Updates
Last Update Posted (ACTUAL)
July 14, 2020
Last Update Submitted That Met QC Criteria
July 12, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013/1237
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Celiac Disease
-
University of OxfordCompletedCeliac Disease | Mental Health Wellness 1 | Emotional Problem | Stigma, Social | Celiac Disease in Children | Celiac | DisclosureUnited Kingdom
-
IRCCS Burlo GarofoloRecruitingCeliac Disease in ChildrenItaly
-
Cairo UniversityNot yet recruitingCeliac Disease in Children
-
Meir Medical CenterTerminatedCeliac Disease in ChildrenIsrael
-
Schneider Children's Medical Center, IsraelUnknownCeliac Disease in ChildrenIsrael
-
University of PalermoCompletedNot-celiac Gluten (Wheat) SensitivityItaly
-
University of PalermoRecruiting
-
University of PalermoCompletedNot-celiac Gluten SensitivityItaly
-
ASST Fatebenefratelli SaccoNot yet recruiting
-
Leiden University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentEnrolling by invitationCeliac Disease in ChildrenNetherlands
Clinical Trials on Gluten challenge
-
Medical University of WarsawNutricia FoundationUnknown
-
Hospital Mutua de TerrassaCompletedCeliac Disease | Non-celiac Gluten Sensitivity
-
Joslin Diabetes CenterImmusanT, Inc.CompletedType 1 Diabetes | Celiac DiseaseUnited States
-
AmgenCompletedCeliac DiseaseFinland
-
Oslo University HospitalUniversity of Oslo; South-Eastern Norway Regional Health AuthorityCompleted
-
James Cook University, Queensland, AustraliaNational Health and Medical Research Council, Australia; The Prince Charles... and other collaboratorsCompleted
-
Massachusetts General HospitalTerminated
-
University of Southern DenmarkOdense University Hospital; University Hospital Bispebjerg and Frederiksberg; Hospital of Southern Jutland and other collaboratorsNot yet recruitingInflammatory Bowel Diseases | Ulcerative ColitisDenmark
-
University Hospital, Clermont-FerrandCentre de Recherche en Nutrition Humaine d'Auvergne; Institut National de Recherche... and other collaboratorsCompleted
-
Göteborg UniversitySahlgrenska University Hospital, Sweden; University of Skövde; Ekhaga foundationRecruitingDiabetes | Celiac Disease | Metabolic Disease | AutoimmunitySweden